ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Medical University of Innsbruck at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Medical University of Innsbruck takes part in 5 sessions at ESMO 2026 in Madrid. Its work spans molecular profiling and targeted treatment across lung, ovarian and brain cancers. It includes using RNA sequencing to identify therapy-specific molecular patterns in patient-derived lung microtumors.
| Organization | ESMO 2026 Attendance |
|---|---|
Medical University of Innsbruck Innsbruck, Austria | |
Public medical university in Innsbruck, Austria, which staffs the city's university hospital. | Poster Fri Oct 23 13:00–15:00 Bulk RNA sequencing captures therapy-specific molecular signatures in patient-derived NSCLC microtumors Lung & thoracic cancersBiomarkers & precision oncology Satellite Sat Oct 24 18:35–18:55 The Emergence of Targeted Potency – ADCs in PROC Gynaecological cancers Satellite Sat Oct 24 19:35–19:50 Future Directions and Case-Based Application Gynaecological cancers Chair Sun Oct 25 14:45–16:15 Cervical cancer: From prevention to optimal therapy Gynaecological cancers Talk Mon Oct 26 08:30–08:50 Molecular diagnosis for targeted therapies in neuro-oncology Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 17:54–18:06 Invited Discussant LBA12 Gynaecological cancersSarcoma, CNS, head & neck and rare cancers |
Find decision makers at Medical University of Innsbruck
Tell us what you sell and we’ll find the people at Medical University of Innsbruck most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction